Carter to lead Fusion Energy Division at Oak Ridge National Laboratory
The common sounds in the background of daily life – like a refrigerator’s hum, an air conditioner’s whoosh and a heat pump’s buzz – often go unnoticed. These noises, however, are the heartbeat of a healthy building and integral for comfort and convenience.
Carl Dukes’ career as an adept communicator got off to a slow start: He was about 5 years old when he spoke for the first time. “I’ve been making up for lost time ever since,” joked Dukes, a technical professional at the Department of Energy’s Oak Ridge National Laboratory.
Oak Ridge National Laboratory researchers are taking fast charging for electric vehicles, or EVs, to new extremes. A team of battery scientists recently developed a lithium-ion battery material that not only recharges 80% of its capacity in 10
The Department of Energy’s Office of Science has selected three ORNL research teams to receive funding through DOE’s new Biopreparedness Research Virtual Environment initiative.
A new nanoscience study led by a researcher at ORNL takes a big-picture look at how scientists study materials at the smallest scales.
Madhavi Martin brings a physicist’s tools and perspective to biological and environmental research at the Department of Energy’s Oak Ridge National Laboratory, supporting advances in bioenergy, soil carbon storage and environmental monitoring, and even helping solve a murder mystery.
Mike Huettel is a cyber technical professional. He also recently completed the 6-month Cyber Warfare Technician course for the United States Army, where he learned technical and tactical proficiency leadership in operations throughout the cyber domain.
Technologies developed by researchers at ORNL have received six 2023 R&D 100 Awards.
Timothy Gray of ORNL led a study that may have revealed an unexpected change in the shape of an atomic nucleus. The surprise finding could affect our understanding of what holds nuclei together, how protons and neutrons interact and how elements form.
After a highly lauded research campaign that successfully redesigned a hepatitis C drug into one of the leading drug treatments for COVID-19, scientists at ORNL are now turning their drug design approach toward cancer.